Analysts raced to cut price targets on an already struggeling Novo Nordisk stock following disappointing trial results for ...

The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss ...

Chairman Prime Minister's Youth Program Rana Mashhood Ahmad Khan on Tuesday launched the Prime Minister’s Youth Business and ...

The president is expected to address economic growth, foreign policy, and immigration enforcement during his State of the ...

Eris Lifesciences has forged a strategic partnership with Natco Pharma for commercialisation of semaglutide in India.

The failure of its next-generation obesity drug to match Eli Lilly's blockbuster has blown a hole in Novo's post-Ozempic ...

Mexican President Claudia Sheinbaum is considering suing billionaire Elon Musk for his assertion that she is actually under ...

Eris Lifesciences partners with Natco Pharma to commercialise semaglutide in India in 2026, as rising demand and impending ...

After Queen Mary leaves Australia at the end of her first official royal visit to Australia as Queen of Denmark next month ...

Novo Nordisk A/S plans to slash the US list prices for its blockbusters Wegovy and Ozempic next year as the drugmaker ...